Anna Cabanes
Impact in
- Oncology top 5%
- Global Cancer Incidence and Screening
- Cancer Risks and Factors
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
- Co-authors
- Marina Pollán (8 shared papers)Beatriz Pérez‐Gómez (5 shared papers)Núria Aragonés (4 shared papers)Gonzalo López‐Abente (4 shared papers)M. Arboix (4 shared papers)Alberto Gabizón (2 shared papers)Enrique Vidal (4 shared papers)Prafulla C. Gokhale (1 shared paper)
- Journals
- JCO Global Oncology (3 papers)Breast Cancer Research and Treatment (3 papers)American Journal of Veterinary Research (2 papers)Supportive Care in Cancer (2 papers)Cancer (2 papers)
- Partner nations
- United StatesSpainZambia
In The Last Decade
Anna Cabanes
39 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 114
- Oncology 444
- Biomaterials 135
- Pathology and Forensic Medicine 121
- Pharmaceutical Science 41
- Cancer Research 72
Countries citing papers authored by Anna Cabanes
This map shows the geographic impact of Anna Cabanes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Cabanes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Cabanes more than expected).
Fields of papers citing papers by Anna Cabanes
This network shows the impact of papers produced by Anna Cabanes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Cabanes. The network helps show where Anna Cabanes may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Cabanes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 119 | |
| 2 | 1998 | 91 | |
| 3 | 2020 | 79 | |
| 4 | Comparative study of the antitumor activity of free doxorubicin and polyethylene glycol-coated liposomal doxorubicin in a mouse lymphoma model. | 1998 | 64 |
| 5 | 2009 | 61 | |
| 6 | 2001 | 58 | |
| 7 | 2002 | 52 | |
| 8 | 2009 | 51 | |
| 9 | 2011 | 50 | |
| 10 | 2010 | 49 | |
| 11 | Enhancement of antitumor activity of polyethylene glycol-coated liposomal doxorubicin with soluble and liposomal interleukin 2. | 1999 | 46 |
| 12 | 1992 | 44 | |
| 13 | 2013 | 44 | |
| 14 | 2004 | 39 | |
| 15 | 2011 | 36 | |
| 16 | 2009 | 29 | |
| 17 | 2018 | 26 | |
| 18 | 2007 | 24 | |
| 19 | 2012 | 22 | |
| 20 | 2008 | 20 |
About Anna Cabanes
Anna Cabanes is a scholar working on Oncology, Genetics, Molecular Biology, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health, having authored 40 papers that have together received 1.2k indexed citations. Recurring topics across this work include Global Cancer Incidence and Screening (11 papers), Cancer Risks and Factors (6 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Advanced Drug Delivery Systems (4 papers), BRCA gene mutations in cancer (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Cervical Cancer and HPV Research (3 papers) and Economic and Financial Impacts of Cancer (3 papers). The work is most often cited by research in Oncology (444 citations), Biomaterials (135 citations), Pathology and Forensic Medicine (121 citations), Pharmaceutical Science (41 citations) and Cancer Research (72 citations). Anna Cabanes has collaborated with scholars based in United States, Spain and Zambia. Frequent co-authors include Marina Pollán, Beatriz Pérez‐Gómez, Núria Aragonés, Gonzalo López‐Abente, M. Arboix, Alberto Gabizón, Enrique Vidal, Prafulla C. Gokhale, A Rahman and Joseph Treat. Their work appears in journals such as JCO Global Oncology, Breast Cancer Research and Treatment, American Journal of Veterinary Research, Supportive Care in Cancer and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.